Breathing guided exercise: Breathing guided exercise are divided into six sections: relaxing standing, two fields breathing, regulating lung and kidney, turning side finger, running kidney hall and nourishing qi and collecting gong. Exercise time: 5 days a week, 1 to 2 times a day, a total of 24 weeks.
Flat walking training: Flat walking training can be performed either outdoors or on flat indoor surfaces at a steady pace of 80 to 120 steps per minute for at least 30 minutes each session, raising the heart rate to the target range and maintaining it for over 10 minutes. This should be done 3 to 5 times a week, with 1 to 2 sessions each day, for a total of 24 weeks. The intensity of the exercise is moderate. The target heart rate based on heart rate reserve is calculated as (maximum heart rate during exercise - resting heart rate) × (40-60)% + resting heart rate.
Study summary
This study aims to evaluate the clinical efficacy of breath-guided improvement of COPD exercise ability, establish a breath-guided rehabilitation program of intelligent iot and remote home, improve COPD exercise ability, reduce acute exacerbation, and form high-quality clinical evidence.
Eligibility
Sex
ALL
Min age
40 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria:
* Patients with COPD in stable stage
* Patients with grade 2 to 4 lung function
* Age 40\~80 years old
* Be able to use smart phones, computers and other devices independently or with the help of family members during home training
* Volunteer for treatment and sign an informed consent form
Exclusion Criteria:
* Pregnant or lactating women and patients with recent pregnancy plans
* Delirious, dementia, all kinds of mental illness
* Tumor patients who have undergone resection, radiation, and chemotherapy within 5 years
* Patients with severe osteoarthropathy or osteoporosis, unstable fractures
* Patients with severe visual impairment that cannot be improved or who have epilepsy or vertigo and cannot use VR devices
* Patients with progressive neuromuscular disease
* Patients with pulmonary abscess, pulmonary interstitial fibrosis, active pulmonary tuberculosis, bronchiectasis, pulmonary embolism and other pulmonary diseases
* Patients with severe cardiovascular and cerebrovascular diseases (malignant arrhythmia, unstable angina pectoris, acute myocardial infarction, grade 3 or above cardiac function, stroke, cerebral hemorrhage, etc.)
* Patients with severe liver disease (cirrhosis, portal hypertension and bleeding caused by esophageal and gastric varices, etc.) and severe kidney disease (dialysis, kidney transplantation, etc.)
* Participants who were participating in other clinical trials within 1 month prior to enrollment
* People who stay in bed for a long time for various reasons
Primary outcome measure(s)
6 Minutes Walking Distance Test (6MWD) — Changes in baseline 6MWD test at weeks 12 and 24 of the treatment period and at 28 weeks of follow-up. The 6-minute walking distance of the two groups was calculated
Trial sites (1)
Facility
City
Region
Status
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Zhengzhou
Henan
More Henan University of Traditional Chinese Medicine trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.